Company profile: LightDeck
1.1 - Company Overview
Company description
- Provider of on-the-spot diagnostic products delivering fast, accurate, low-cost, lab-quality results in minutes via a proprietary laser waveguide platform. Offerings include a 5-minute COVID-19 antigen test; developing hormone, host-response, and cardiac marker panels; environmental tests for harmful algae blooms; and point-of-care veterinary diagnostics with Heska.
Products and services
- Cardiac Markers Panel: An on-the-spot panel assessing chest pain using high-sensitivity troponin, NT-proBNP, and D-dimer assays, delivering 15-minute, lab-quality results via LightDeck’s advanced laser waveguide platform
- Host Response Panels: A biomarker-based blood panel quantifying host-response indicators of inflammation, potentially prognostic for cytokine storm in COVID-19 and sepsis, engineered for fast, accurate, simple testing anywhere
- COVID-19 Antigen Test: A point-of-care antigen assay detecting current SARS-CoV-2 infection and producing results in approximately 5 minutes, enabling lab-quality diagnostics through novel materials and patented manufacturing techniques
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LightDeck
NanoRepro
HQ: Germany
Website
- Description: Provider of rapid medical self-tests and diagnostics, developing, manufacturing, and distributing products for domestic and clinical use across women's health, fertility, prevention, family planning, health care, allergies, and food intolerance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoRepro company profile →
CTK Biotech
HQ: United States
Website
- Description: Provider of innovative immunodiagnostic tools and point-of-care diagnostic test kits for the IVD community worldwide, including SARS-CoV-2 rapid antigen, antibody, and real-time PCR tests; a self-administered COVID-19 home antigen test; an OnSite dengue IgG rapid test in the CDC two-step algorithm; and an HIV 1/2 antibody rapid test approved for commercialization in the EU.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTK Biotech company profile →
Cordant Health Solutions
HQ: United States
Website
- Description: Provider of drug testing and case-management solutions for health, chronic pain, and criminal justice, including Cordant Sentry for automated patient testing randomization, real-time results, and compliance alerts; urine, oral fluid, hair, and blood drug testing; and behavioral health solutions with laboratory testing, pharmacy services, and adherence monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cordant Health Solutions company profile →
Abraxis
HQ: Trinidad and Tobago
Website
- Description: Provider of rapid test kits and related products for environmental, water quality, food/agriculture, and life sciences, including ELISA, lateral flow, and magnetic particle assay kits; standards and QC materials (certified reference materials and check samples); lab testing equipment (automated analyzers and manual test strip readers); AbraMag magnetic beads; and BACGro dehydrated and prepared culture media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abraxis company profile →
MedDX
HQ: United Kingdom
Website
- Description: Provider of compliant packaging products and services for the healthcare sector, specializing in manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedDX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LightDeck
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LightDeck
2.2 - Growth funds investing in similar companies to LightDeck
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LightDeck
4.2 - Public trading comparable groups for LightDeck
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →